Fermentation products produced

There are thousands of breweries worldwide. However, the number of companies using fermentation to produce therapeutic substances and/or fine chemicals number well over 150, and those that grow microorganisms for food and feed number nearly 100. Lists of representative fermentation products produced commercially and the corresponding companies are available (1). Numerous other companies practice fermentation in some small capacity because it is often the only route to synthesize biochemical intermediates, enzymes, and many fine chemicals used in minor quantities. The large volume of L-phenylalanine is mainly used in the manufacture of the artificial dipeptide sweetener known as aspartame [22389-47-0]. Prior to the early 1980s there was httle demand for L-phenyl alanine, most of which was obtained by extraction from human hair and other nonmicrobiological sources. 

Competition for fermentation products produces a succession of dominant metabolic pathways as distance from the source of electron donors and acceptors increases. Aerobic metabolism dominates the surface of sediments, and methanogenesis the deeper depths, as suggested by their free energy yield (Table 1). There is often very little overlap between each zone, suggesting nearly complete exclusion of one group by another. The same pattern is observed with distance from the surface of a root or burrow, or with distance downstream from an organic pollutant source in rivers and aquifers. 

Lactic acid (LA) or 2-hydroxypropanoic acid, is a naturally occurring hydroxycar-boxyhc acid and the sole or main final fermentation product produced by LAB. LA is widely used in the food, pharmaceutical, cosmetic, textile, and chemical industries and it is considered GRAS and recognized as harmless by the US FDA. In the food industry, LA is used as a preservative (acidifier) and flavor-enhancing... 

However, cyclocarbonylation of 2-bromo-3,5-dimethoxybenzyl alcohol 22 was successfully achieved by Shimizu and coworkers in the synthesis of mycophenolic acid 23, a fermentation product produced by a number of penicillum species (Scheme 13.11) [34]. The synthesis was carried out using palladium-catalyzed carbonylation and Heck olefination. Thus, the reaction of 2-bromo-3,... 

After nutrients and substrate begin to diminish, cell growth decelerates and enters a period of no apparent growth. This phase is known as the stationary phase. In the stationary phase, the rate of growth equals the rate of cell death and no net change in cell mass concentration occurs. Fermentation products produced during the stationary phase are known as non-growth associated products. 

Lactic acid is also the simplest hydroxy acid that is optically active. L (+)-Lactic acid [79-33-4] (1) occurs naturally ia blood and ia many fermentation products (7). The chemically produced lactic acid is a racemic mixture and some fermentations also produce the racemic mixture or an enantiomeric excess of D (—)-lactic acid [10326-41-7] (2) (8). 

In the 1950s, a group of coryneform bacteria which accumulate a large amount of L-glutamic acid in the culture medium were isolated (21). The use of mutant derivatives of these bacteria offered a new fermentation process for the production of many other kinds of amino acids (22). The amino acids which are produced by this method are mostiy of the T.-form, and the desired amino acid is singly accumulated. Therefore, it is very easy to isolate it from the culture broth. Rapid development of fermentative production and en2ymatic production have contributed to the lower costs of many protein amino acids and to their availabiUty in many fields as economical raw materials. 

Shordy thereafter, the M-4365 complex of six factors (A —A and G —G ), produced by M. capillata (275,276), was reported. From the izenamicin complex of seven factors produced by a M.icromonospora species, three were new fermentation products (277). Many compounds isolated are identical juvenimicin A, M-4365 A2, and izenamicin A are the same as rosaramicin. Stmctures have been proven by chemical interconversions (261,277,278) and microbial transformations (279). 

Most of the fermentation and isolation processes for manufacture of the tetracyclines are described in patents (71,72). Manufacture begins with the cultivated growth of selected strains of Streptomjces in a medium chosen to produce optimum growth and maximum antibiotic production. Some clinically useful tetracyclines (2—4) are produced directly in these fermentations others (5—7) are produced by subjecting the fermentation products to one or more chemical alterations. The purified antibiotic produced by fermentation is used as the starting material for a series of chemical transformations (59). 

Vancomycin, ristocetin A and teicoplanin are produced as fermentation products of Streptomyces orientalis, Nocardia lurida and Actinoplanes teichomyceticus, respectively. All three of these related compounds consist of an aglycone basket made up of fused macrocyclic rings and pendant carbohydrate moieties (Fig. 2-1). The macrocycles contain both ether and peptide linkages. The aglycones of vancomycin and teicoplanin contain two chloro-substituted aromatic rings, while the analogous portion of ristocetin A contains no chloro substituents. 

We can see that for type 1 processes, high growth rate is obligately linked to a high rate of product formation. Indeed, this is the case for all products produced by a fermentative mode of metabolism, eg ethanol, lactic add, acetone. Chemostat studies have shown that for most aerobic processes when growth is limited by some nutrient other than the carbon source, the yield of product decreases with increase in spedfic growth rate (p or D p = dilution rate (D) in chemostat culture). Conversely, both the biomass yield and the spedfic rate of substrate utilisation (qs g substrate g biomass-1 h-1) increase with spedfic growth rate. 

In addition to dtrate, there are other addic intermediates of file TCA cyde and several of these are used in industry. Even though some have been produced by fermentation, production is currently from other, cheaper sources. 

Bacteria, yeast and algae are produced in massive quantities of protein sources as food for animals and humans.1 SCP is considered a major source of feed for animals. The production of valuable biological products from industrial and agricultural wastes is considered through the bioconversion of solid wastes to added-value fermented product, which is easily marketable as animal feedstock. The waste streams that otherwise would cause pollution and threaten the environment can be considered raw material for CSP production using suitable strains of microorganisms. 

It is possible to convert penicillin V or benzylpenieillin to a cephalosporin by chemical ring expansion. The first-generation cephalosporin cephalexin, for example, can be made in this way. Most cephalosporins used in clinical practice, however, are semisynthetics produced from the fermentation product cephalosporin C. 

---